This inventor holds 1 USPTO granted patent. Top assignee: Quest International B.v.. Active years: 1999.
Company Filing History:
Years Active: 1999
Title: The Innovations of Eric Emond
Introduction
Eric Emond is a notable inventor based in Sillery, Canada. He has made significant contributions to the field of biotechnology, particularly in the area of phage resistance in dairy cultures. His work has implications for improving the resilience of dairy starter cultures against bacteriophage infections.
Latest Patents
Eric Emond holds a patent for a novel protein known as Abi900, which consists of 183 amino acids. This protein and its gene were isolated from a natural plasmid, pSRQ900, derived from Lactococcus lactis. When introduced into dairy starter cultures, the Abi900 protein provides strong resistance to bacteriophage infection. He has 1 patent to his name.
Career Highlights
Emond is currently employed at Quest International B.V., where he continues to innovate in the field of biotechnology. His work focuses on enhancing the stability and effectiveness of dairy cultures, which is crucial for the dairy industry.
Collaborations
Throughout his career, Eric has collaborated with esteemed colleagues such as Shirley A Walker and Ebenezer R Vedamuthu. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Eric Emond's contributions to biotechnology, particularly through his patent on the Abi900 protein, highlight his role as an influential inventor in the field. His work not only advances scientific knowledge but also has practical applications in the dairy industry.